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QUANTITATION OF SERUM ERYTHROPOIETIC STIMULATORY AND INHIBITORY ACTIVI-
TIES USING 3 H-THYMIDINE UPTAKE BY K562 CELLS. J. P. Lewis* and 
A. E. Felice**, Hemoglobin Research Laboratory, Medical Research 
Service, Veterans Administration Medical Center, and Departments of Cell 
and Molecular Biology, Pediatrics, and Medicine, Medical College of 
Georgia, Augusta, GA. 
Cells of the human pluripotent leukemia cell line K562 exhibit 
erythroid properties such as glycophorin and hemoglobin synthesis. 
We examined the response of K562 cells to erythropoietin in terms of 
3H-thymidine uptake as described by Krystal et al for spleen cells from 
anemic mice pretreated with phenylhydrazine (Exp. Hematol. 11: 649, · 
1983). Both murine spleen cells and K562 cells gave the same dose 
response curve, i.e. 103 cpm/103 cells/mu erythropoietin. Thus, the 
K562 cells could be used instead of the murine spleen cells in the 
Krystal assay for erythropoietic activity in serum. With this assay, 
nine healthy volunteers with normal blood counts gave erythropoietin 
levels of 356 ± 10 (SD) mU/ml. Sera of 24 children with sickle cell 
disease gave levels between 289 and 1835 mU/ml (average is 589 ± 66 
(SD) mU/ml). Addition of an anti-erythropoietic inhibitory factor 
antiserum, or dilution of sera led to increased 3H-thymidine uptake. 
Thus, 3H-thymidine uptake reveals the presence of physiological 
erythropoietin receptors on K562 cells and can be used to measure 
erythropoietic and anti-erythropoietic activities in sera of patients. 
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